Your browser doesn't support javascript.
loading
Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers.
Liu, Fangcen; Zhong, Fangfang; Wu, Huan; Che, Keying; Shi, Jiaochun; Wu, Nandie; Fu, Yao; Wang, Yue; Hu, Jing; Qian, Xiaoping; Fan, Xiangshan; Wang, Weifeng; Wei, Jia.
Afiliação
  • Liu F; Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University, Nanjing, People's Republic of China.
  • Zhong F; Department of Pathology, Margaret Williamson Red House Hospital, Shanghai, People's Republic of China.
  • Wu H; Department of R&D, OrigiMed, Shanghai, People's Republic of China.
  • Che K; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People's Republic of China.
  • Shi J; Department of R&D, OrigiMed, Shanghai, People's Republic of China.
  • Wu N; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People's Republic of China.
  • Fu Y; Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University, Nanjing, People's Republic of China.
  • Wang Y; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People's Republic of China.
  • Hu J; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People's Republic of China.
  • Qian X; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People's Republic of China.
  • Fan X; Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University, Nanjing, People's Republic of China.
  • Wang W; Department of R&D, OrigiMed, Shanghai, People's Republic of China.
  • Wei J; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People's Republic of China.
Oncologist ; 28(3): e136-e144, 2023 03 17.
Article em En | MEDLINE | ID: mdl-36724040
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article